Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pre-hospital thrombolytic therapy].

Terje K Steigen1, Rune Wiseth, Jan Erik Nordrehaug

  • 1Hjertemedisinsk avdeling, Universitetssykehuset Nord-Norge, 9038 Tromsø. terje.steigen@UNN.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|March 9, 2004
PubMed
Summary

Pre-hospital thrombolysis is crucial for ST-elevation myocardial infarction when percutaneous coronary intervention is delayed. Early pharmacological reperfusion improves outcomes, especially in geographically challenging areas like Norway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Prehospital resuscitative endovascular balloon occlusion of the aorta in non-traumatic out-of-hospital cardiac arrest (REBOARREST): an international, multicentre, open label, pragmatic, randomised, controlled trial.

Critical care (London, England)·2026
Same author

Secondary prevention with beta-blockers after myocardial infarction.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same author

Secondary prevention in coronary artery disease: the need for intensified efforts.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2025
Same author

Relevance of autoregulation in the diagnosis of coronary artery disease with CT-FFR.

American journal of physiology. Heart and circulatory physiology·2025
Same author

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure.

The New England journal of medicine·2025

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Thrombolytic therapy is a well-established treatment for ST-elevation myocardial infarction (STEMI).
  • Pre-hospital administration offers a significant advantage due to its ease of use.
  • Percutaneous coronary intervention (PCI) is an alternative reperfusion strategy.

Purpose of the Study:

  • To review thrombolytic treatment for STEMI, focusing on pre-hospital applications.
  • To compare thrombolysis with PCI in the context of geographical limitations and treatment times.
  • To explore optimal reperfusion strategies for STEMI patients.

Main Methods:

  • Review of international publications on thrombolytic therapy and PCI for STEMI.
  • Analysis of treatment outcomes based on timing and geographical accessibility.

Related Experiment Videos

  • Consideration of clinical guidelines and expert experience.

    • Main Results:

    • PCI generally shows better outcomes than thrombolysis if performed promptly in invasive centers.
    • Geographical factors in Norway may hinder timely PCI for all STEMI patients.
    • Early pharmacological reperfusion is recommended if primary PCI is not feasible within 90 minutes.

    Conclusions:

    • Pre-hospital thrombolysis remains vital for STEMI management, particularly when PCI is delayed.
    • Late-presenting STEMI (6-12 hours) may benefit more from PCI due to reduced thrombolysis efficacy.
    • Developing pre-hospital thrombolytic therapy infrastructure across Norway is essential for improving STEMI care.